The Vaccine Quarterly Online

Supported by an educational grant from Merck & Co., Inc., this journal is free and there is no charge for the 2 CME credits offered in each issue. To receive a FREE subscription to The Vaccine Quarterly, please send an e-mail request with your name, a complete mailing address, and the title (The Vaccine Quarterly) that you are interested in receiving to: marilyn.besen@wolterskluwer.com


Release Date

Four individual CME activities are available through the journal each year.

uparrow Back to Top of Page

Credit Hours

The Lippincott CME Institute, Inc. designates this educational activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

An annual total of 8 AMA PRA Category 1 Credits™ are available through the four annual issues of The Vaccine Quarterly.

uparrow Back to Top of Page

Commercial Support

This CE activity is supported by an unrestricted educational grant from Merck & Co., Inc. Additional educational grant support for this CME program has been provided by MedImmune Inc.

uparrow Back to Top of Page

Target Audience

This CME activity is intended for pediatricians and family practitioners.

uparrow Back to Top of Page

Statement of Needs

In 1982, the routine childhood immunization schedule consisted of seven shots and four doses of oral polio vaccine. Seven diseases were considered vaccine-preventable. The 2007 routine childhood immunization schedule calls for as many as 37 shots and 3 doses of an oral vaccine; 16 diseases are now considered vaccine-preventable. In fact, the schedule has become so complicated that is has been split into two versions: one for children 0 to 6 years of age and another for children 7 to 18 years of age.

In the last two years alone, new vaccines have been licensed for boosting pertussis immunity; preventing invasive meningococcal disease; preventing severe rotavirus diarrhea; and preventing cervical cancer from human papilloma virus infection. In addition, new recommendations have been issued for use of varicella, influenza, mumps, and hepatitis A vaccines. While these advancements are extremely good news in terms of public health, all of this is also terribly burdensome and confusing for practitioners. Physicians are continuously bombarded with vaccine information, but it comes from all directions and in piecemeal fashion.

The purpose of The Vaccine Quarterly (TVQ) is to distill this cacophony of vaccine information into a durable product that is readable, relevant, concise, academic, and practical. Each journal issue will have three components: 1) a Literature Review Section, wherein eight recent primary scientific articles that are of particular importance to vaccination providers will be reviewed; 2) an Editor’s Section, wherein new recommendations, licensures, and other vaccine news will be highlighted; and 3) an invited Guest Article, written by a preeminent expert in the field and addressing a timely vaccine topic.

Participants are expected to be up-to-date on the latest authoritative vaccine recommendations, so as to deliver the best care to their patients. In addition, they are expected to gain insight into the latest scientific research related to vaccines and vaccine-preventable diseases.

This CME program will be presented in an online journal format, which will be available at no cost to members of the target audience by LCMEI. Practitioners will have a self-test opportunity to reinforce their learning experience and to obtain CME credits. An evaluation assessment questionnaire following the CME examination will confirm the quality of the educational activity, the value and use of the learned material in their practice, confirm the activity credit designation, gauge the fairness and balance of the activity, and provide practitioners with the opportunity to suggest topics for future LCMEI CME activities.

uparrow Back to Top of Page

Faculty Credentials/Disclosure

Faculty and author affiliations and financial disclosure information are procured and printed prior to each CME article in each issue.

Editor-in-Chief

Gary S. Marshall, MD

Professor of Pediatrics
Chief, Division of Pediatric Infectious Diseases
University of Louisville School of Medicine
Louisville, Kentucky

Dr. Marshall has disclosed that he had/has the following financial relationships with commercial companies:
Grant/Research Funding: GlaxoSmithKline, Merck & Co., Inc., Sanofi Pasteur;
Consultant/Advisor: GlaxoSmithKline, Merck & Co., Inc., Sanofi Pasteur;
Speakers Bureau: GlaxoSmithKline, Merck & Co., Inc., Sanofi Pasteur.

Editorial Board

James H. Conway, MD

Associate Professor of Pediatrics
University of Wisconsin School of Medicine
and Public Health
Madison, Wisconsin

Dr. Conway has disclosed that he had/has the following financial relationships with commercial companies:
Grant/Research Funding: Merck Foundation
Consultant/Advisor: Merck & Co., Inc.
Speakers Bureau: Merck & Co., Inc.; Sanofi Pasteur

Sharon G. Humiston, MD, MPH
Associate Professor of Emergency Medicine and Pediatrics
University of Rochester School of Medicine and Dentistry
Rochester, New York

Dr. Humiston has disclosed that she has the following financial relationships with commercial companies:
Consultant/Advisor: GlaxoSmithKline, Merck & Co. Inc., Sanofi Pasteur;
Speakers Bureau: GlaxoSmithKline, Merck & Co. Inc., Sanofi Pasteur;

Dr. Humiston has disclosed that she or her employer had received, directly or indirectly, honorarium or salary support over the last 12 months from the National Immunization Program of the Centers for Disease Control and Prevention and the New York State Department of Health; from the vaccine advisory boards of GlaxoSmithKline and Merck Vaccine Division; from continuing medical education talks or papers sponsored by state health departments e.g., Michigan and New York), private healthcare provider organizations and private foundations (e.g., National Association of Pediatric Nurse Practitioners, Medical Society of the State of New York, and National Foundation for Infectious Diseases), private continuing medical education companies (e.g., STI, CME LLC), and pharmaceutical companies (GlaxoSmithKline, Merck Vaccine Division, and Sanofi Pasteur); and from promotional talks sponsored by Merck Vaccine Division and Sanofi Pasteur.

Jay M. Lieberman, MD
Chief, Pediatric Infectious Diseases
Miller Children’s Hospital
Long Beach, California
Professor of Clinical Pediatrics
University of California, Irvine

Dr. Lieberman has disclosed that he had the following financial relationships with commercial companies:
Grant/Research: MedImmune, Merck & Co., Inc.;
Consultant/Advisor: MedImmune, Merck & Co., Inc.;
Speakers Bureau: GlaxoSmithKline, MedImmune, Merck & Co., Inc., Sanofi Pasteur;

Dr. Lieberman has disclosed that he has the following Financial relationships with commercial companies:
Grant/Research: MedImmune, Merck & Co., Inc.;
Speakers Bureau: GlaxoSmithKline, MedImmune, Merck & Co., Inc., Sanofi Pasteur

Charles R. Woods, MD, MS
Professor of Pediatrics (Infectious Diseases)
Department of Pediatrics
University of Louisville School of Medicine
Louisville, Kentucky

Dr. Woods has disclosed that he had the following financial relationships with commercial companies:
Grant/Research: Merck & Co., Inc.,
Speakers Bureau: Merck & Co., Inc., Sanofi-Pasteur

Dr. Woods has disclosed that he has the following Financial relationships with commercial companies:
Grant Research: Sanofi-Pastuer
Speakers Bureau: Merck & Co., Inc., Sanofi-Pasteur

Other Staff (LCMEI, WKH, Other)

All other persons in a position to control the content of this CME activity have disclosed that they have no financial relationships with, or financial interests in, any commercial companies pertaining to this educational activity.

uparrow Back to Top of Page

Identification and Resolution of Conflict of Interests

Lippincott CME Institute, Inc. has identified and resolved any faculty and staff conflicts of interest regarding this educational program and individual activities.

uparrow Back to Top of Page

Learning Objectives

Learning objectives for each CME activity are procured and printed prior to each CME article in each issue.

uparrow Back to Top of Page

Accreditation

The Lippincott CME Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

uparrow Back to Top of Page

Method of Participation

Physicians
To earn CME credit, a participant must review the CME Overview information, read the activity content, and complete the online CME Quiz/Evaluation Assessment questionnaire, answering at least 70% of the quiz questions correctly. A participant must elect the best answer and place a check mark in the corresponding space on the answer screen. Upon completion, the subscriber clicks the "Send" button and submits the exam for grading. Upon achieving a passing score, participants are provided with a certificate .pdf to print out on their own computers.

uparrow Back to Top of Page

Evaluation Method

Eight evaluation assessment questions are included as part of the CME Quiz in each activity. These questions ensure that Lippincott CME Institute determines that each activity’s learning objectives have been met, that the activity was of educational value to the target audience and was unbiased, assess whether or not the CME activity has resulted in a change in physician practice behavior, and offer participants a method of feedback.
 

uparrow Back to Top of Page

LCMEI Privacy Policy

The Lippincott CME Institute, Inc. has created this privacy statement in order to demonstrate our firm commitment to the privacy of our customers. The following discloses our practices on gathering and disseminating information for this web site.

LCMEI has security measures in place to protect the loss, misuse and alteration of the information under our control. LCMEI does not share or sell any individual's contact information, financial information, or unique identifiers to any commercial supporter, advertiser or third party without the specific permission of the individual.

If you have any questions about this privacy statement, the practices of this site, or your dealings with this web site, you can contact:

James T. Magrann
Executive Director of Continuing Education
Lippincott CME Institute, Inc.
Jay.Magrann@wolterskluwer.comuparrow Back to Top of Page

 

Hardware and Software Requirements

Participants must have Internet access and the correct browser software (Internet Explorer version 5.5 and higher or Netscape 7.02 and higher). If your browser is not current, please click on the specific link below to download the appropriate software (free of charge), by visiting the Microsoft or Netscape web site. To maximize your viewing, we suggest that you set your monitor resolution to 1024 x 768 pixels. Site can viewed 800 x 600 pixels but frame scrolling will result.

PC
Windows 98, SE or above
Internet Explorer 5.5 or above
Netscape 7.02 or above
800 x 600 Minimum Monitor Resolution
(1024 x 768 Recommended)
Adobe Acrobat Reader
(Printable Version Only)

MAC
Mac OS 10.2
It is recommended that Macintosh owners use Netscape 7.02 and NOT Internet Explorer when viewing this activity. Internet Explorer is not supported on the Macintosh.
Netscape 7.02 only
800 x 600 Minimum Monitor Resolution
(1024 x 768 Recommended)
Adobe Acrobat Reader
(Printable Version Only)

uparrow Back to Top of Page

Participant Support

CECity.com Technical Support

If you have any questions about your access to this CPE activity or problems with completing the post-test/evaluation, please contact support@cecity.com. Call CECity Toll-Free at 1-888-My-CECity (1-866-692-3248), Monday-Friday 9AM to 6PM EST

LCMEI, Inc. Online CME Support

If you have any content-related questions about the online CPE activities, please feel free to contact LCMEI, Inc. at 1-267-757-3531.

uparrow Back to Top of Page

Participation Expiration Date

The expiration date for each individual activity in this CME program is provided in each activity.

uparrow Back to Top of Page

Back to Continuing Education Center Listing